BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand 2020;141:304-15. [PMID: 31774547 DOI: 10.1111/acps.13134] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Salagre E, Rohde C, Ishtiak-ahmed K, Gasse C, Østergaard SD. Survival Rate Following Involuntary Electroconvulsive Therapy: A Population-Based Study. J ECT 2021;37:94-9. [DOI: 10.1097/yct.0000000000000736] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Singh A, Khanna P. COVID-19 Pandemic and Electroconvulsive Therapy. Journal of Neuroanaesthesiology and Critical Care 2020;7:150-3. [DOI: 10.1055/s-0040-1714916] [Reference Citation Analysis]
3 Kellner CH. Electroconvulsive Therapy: Stayin' Alive, Stayin' Well. Acta Psychiatr Scand 2021;144:215-7. [PMID: 34397107 DOI: 10.1111/acps.13352] [Reference Citation Analysis]
4 Sharma RK, Kulkarni G, Kumar CN, Arumugham SS, Sudhir V, Mehta UM, Mitra S, Thanki MV, Thirthalli J. Antidepressant effects of ketamine and ECT: A pilot comparison. Journal of Affective Disorders 2020;276:260-6. [DOI: 10.1016/j.jad.2020.07.066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kutzer T, Dick M, Scudamore T, Wiener M, Schwartz T. Antidepressant efficacy and side effect burden: an updated guide for clinicians. Drugs Context 2020;9:2020-2-2. [PMID: 32523610 DOI: 10.7573/dic.2020-2-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Hajak VL, Hajak G, Ziegelmayer C, Grimm S, Trapp W. Risk Assessment of Electroconvulsive Therapy in Clinical Routine: A 3-Year Analysis of Life-Threatening Events in More Than 3,000 Treatment Sessions. Front Psychol 2021;12:767915. [PMID: 34887815 DOI: 10.3389/fpsyg.2021.767915] [Reference Citation Analysis]
7 Osler M, Rozing MP, Jorgensen MB, Jorgensen A. Mortality and acute somatic events following electroconvulsive therapy in patients with pre-existing somatic comorbidity - A register-based nationwide Danish cohort study. World J Biol Psychiatry 2021;:1-9. [PMID: 34668447 DOI: 10.1080/15622975.2021.1995808] [Reference Citation Analysis]
8 Lambrichts S, Detraux J, Vansteelandt K, Nordenskjöld A, Obbels J, Schrijvers D, Sienaert P. Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis. Acta Psychiatr Scand 2021;143:294-306. [PMID: 33506961 DOI: 10.1111/acps.13277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ulbrich L, Kröger C. Value of Electroconvulsive Therapy in the General Public: A Willingness to Pay Study in Germany. J ECT 2021;37:51-7. [PMID: 33009216 DOI: 10.1097/YCT.0000000000000721] [Reference Citation Analysis]
10 Lambrichts S, Vansteelandt K, Crauwels B, Obbels J, Pilato E, Denduyver J, Ernes K, Maebe PP, Migchels C, Roosen L, Buggenhout S, Bouckaert F, Schrijvers D, Sienaert P. Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic. Acta Psychiatr Scand 2021;144:230-7. [PMID: 34086984 DOI: 10.1111/acps.13334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mcgilloway A. Are we withholding the most effective treatment for severe depression from our patients? BJPsych advances 2021;27:303-4. [DOI: 10.1192/bja.2021.44] [Reference Citation Analysis]
12 Iwanaga H, Ueno T, Oribe N, Hashimoto M, Nishimura J, Nakayama N, Haraguchi N, Tateishi H, Kunitake Y, Mizoguchi Y, Monji A. Correlation between Post-Acute Electroconvulsive Therapy Alpha-Band Spectrum Power Increase and Improvement of Psychiatric Symptoms. J Pers Med 2021;11:1315. [PMID: 34945787 DOI: 10.3390/jpm11121315] [Reference Citation Analysis]
13 Sienaert P, Lambrichts S, Popleu L, Van Gerven E, Buggenhout S, Bouckaert F. Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait. Am J Geriatr Psychiatry 2020;28:772-5. [PMID: 32345550 DOI: 10.1016/j.jagp.2020.04.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
14 Goh SE, Tor PC. Selecting right unilateral placement to facilitate continuation of electroconvulsive therapy following prolonged seizures. Asian J Psychiatr 2021;66:102874. [PMID: 34624745 DOI: 10.1016/j.ajp.2021.102874] [Reference Citation Analysis]
15 Obbels J, Vansteelandt K, Bouckaert F, Dols A, Stek M, Verwijk E, Sienaert P. Neurocognitive functioning after electroconvulsive therapy in late-life depression: A 4-year prospective study. Acta Psychiatr Scand 2021;143:141-50. [PMID: 33150605 DOI: 10.1111/acps.13252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Dominiak M, Antosik-Wójcińska AZ, Goetz Z, Sikorska O, Stefanowski B, Gorostiza D, Święcicki Ł. Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trial. J Psychiatr Res 2021;133:52-9. [PMID: 33310500 DOI: 10.1016/j.jpsychires.2020.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Obbels J, Vansteelandt K, Verwijk E, Lambrichts S, Bouckaert F, Sienaert P. Understanding electroconvulsive therapy-related anxiety: a prospective study. Acta Psychiatr Scand 2020;142:132-40. [PMID: 32474903 DOI: 10.1111/acps.13198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Takamiya A, Bouckaert F, Sienaert P, Uchida T, Kudo S, Yamagata B, Kishimoto T, Mimura M, Hirano J. Electroconvulsive Therapy for Patients With Depression Who Lack Capacity for Consent: Doing Good and Doing No Harm. J ECT 2021;37:171-5. [PMID: 33840801 DOI: 10.1097/YCT.0000000000000764] [Reference Citation Analysis]
19 Kocamer Şahin Ş, Demir B, Elboğa G, Altındağ A, Elmalı E. The Effects of Maintenance Electroconvulsive Therapy on Hospitalization Rates. J Nerv Ment Dis 2021;209:155-8. [PMID: 33273396 DOI: 10.1097/NMD.0000000000001278] [Reference Citation Analysis]
20 Maffioletti E, Minelli A, Tardito D, Gennarelli M. Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments. Genes (Basel) 2020;11:E1089. [PMID: 32961910 DOI: 10.3390/genes11091089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ulbrich L, Kröger C. Monetary valuation of a Quality-Adjusted Life Year (QALY) for depressive disorders among patients and non-patient respondents: A matched willingness to pay study. Clin Psychol Eur 2021;3:e3855. [DOI: 10.32872/cpe.3855] [Reference Citation Analysis]
22 Edinoff AN, Kaufman SE, Hollier JW, Virgen CG, Karam CA, Malone GW, Cornett EM, Kaye AM, Kaye AD. Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges. Neurol Int 2021;13:570-86. [PMID: 34842777 DOI: 10.3390/neurolint13040057] [Reference Citation Analysis]
23 Steinholtz L, Reutfors J, Brandt L, Nordanskog P, Thörnblom E, Persson J, Bodén R. Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity. J Affect Disord 2021;292:276-83. [PMID: 34134026 DOI: 10.1016/j.jad.2021.05.078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhou Z, Wang K, Tang J, Wei D, Song L, Peng Y, Fu Y, Qiu J. Cortical thickness distinguishes between major depression and schizophrenia in adolescents. BMC Psychiatry 2021;21:361. [PMID: 34284747 DOI: 10.1186/s12888-021-03373-1] [Reference Citation Analysis]
25 Munkholm K, Jørgensen KJ, Paludan-müller AS; Cochrane Common Mental Disorders Group. Electroconvulsive therapy for preventing relapse and recurrence in people with depression. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd015164] [Reference Citation Analysis]
26 Trifu S, Sevcenco A, Stănescu M, Drăgoi AM, Cristea MB. Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (Review). Exp Ther Med 2021;22:1281. [PMID: 34630636 DOI: 10.3892/etm.2021.10716] [Reference Citation Analysis]
27 Surve RM, Sinha P, Baliga SP, M R, Karan N, Jl A, Arumugham S, Thirthalli J. Electroconvulsive therapy services during COVID-19 pandemic. Asian J Psychiatr 2021;59:102653. [PMID: 33845300 DOI: 10.1016/j.ajp.2021.102653] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Clermont A, Loubriel D, Li E, Mitera D, Samuels S. Electroconvulsive therapy in an adolescent patient with catatonia: a case report. Neurocase 2021;27:18-21. [PMID: 33297838 DOI: 10.1080/13554794.2020.1859545] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Gbyl K, Støttrup MM, Mitta Raghava J, Xue Jie S, Videbech P. Hippocampal volume and memory impairment after electroconvulsive therapy in patients with depression. Acta Psychiatr Scand 2021;143:238-52. [PMID: 33251575 DOI: 10.1111/acps.13259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]